Healthcare >> CEO Interviews >> December 18, 2000

Ralph Christoffersen – Ribozyme Pharmaceuticals Inc (rzym)

RALPH E. CHRISTOFFERSEN joined RPI as its President and Chief Executive Officer in June 1992. He formerly served as Senior Vice President for Research at SmithKline Beecham, Vice President for Discovery Research at The Upjohn Company, President of Colorado State University, and Vice Chancellor for Academic Affairs and Professor of Chemistry at the University of Kansas. He is currently a member of the Genomica Corporation Board, the Colorado Biotechnology Association Board and the Biotechnology Industry Organization (BIO) Board. Dr. Christofferson received an Honorary Doctor of Law degree from Cornell College in 1983, the Outstanding Researcher of Year Award from the International Society of Quantum Biology in 1981, and W. E. Upjohn Award for contributions in Biotechnology in 1988. Dr. Christoffersen received his Bachelor of Science in Chemistry and Mathematics from Cornell College, and PhD in Chemistry from Indiana University. Profile
TWST: Would you mind providing our readers with an overview of Ribozyme

Pharmaceuticals?

Dr. Christoffersen: The company was formed in 1992 and the technology

that formed the basis for the